| URL | http://www.fiercepharmamanufacturing.com/story/aur |
| Source | FiercePharma Manufacturing |
| Date Published | 10/29/2015 |
| Author Name | Eric Palmer |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Aurobindo |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Year reshoring announced: | 2015 |
| Country(ies) from which reshored: | India |
| City reshored to: | East Windsor |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market |